These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27363900)

  • 41. [Synergistic apoptotic effect of the combination of diosgenin and TRAIL on non-small-cell lung cancer cell line A549 evaluated with the Chou-Talalay method].
    He Y; Wang JS; Zhang P; Zhang WJ; Huang QL; Hua ZC
    Yao Xue Xue Bao; 2013 Jan; 48(1):45-51. PubMed ID: 23600140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Xu HB; Li L; Liu GQ
    Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1.
    Sutter AP; Maaser K; Grabowski P; Bradacs G; Vormbrock K; Höpfner M; Krahn A; Heine B; Stein H; Somasundaram R; Schuppan D; Zeitz M; Scherübl H
    J Hepatol; 2004 Nov; 41(5):799-807. PubMed ID: 15519653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
    Zantl N; Weirich G; Zall H; Seiffert BM; Fischer SF; Kirschnek S; Hartmann C; Fritsch RM; Gillissen B; Daniel PT; Häcker G
    Oncogene; 2007 Oct; 26(49):7038-48. PubMed ID: 17486061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Grade-dependent effects on cell cycle progression and apoptosis in response to doxorubicin in human bladder cancer cell lines.
    Stravopodis DJ; Karkoulis PK; Konstantakou EG; Melachroinou S; Lampidonis AD; Anastasiou D; Kachrilas S; Messini-Nikolaki N; Papassideri IS; Aravantinos G; Margaritis LH; Voutsinas GE
    Int J Oncol; 2009 Jan; 34(1):137-60. PubMed ID: 19082486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro.
    Khdair A; Handa H; Mao G; Panyam J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):214-22. PubMed ID: 18796331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two hits are better than one: synergistic anticancer activity of α-helical peptides and doxorubicin/epirubicin.
    Zhao J; Huang Y; Liu D; Chen Y
    Oncotarget; 2015 Jan; 6(3):1769-78. PubMed ID: 25593197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells.
    Ho TS; Ho YP; Wong WY; Chi-Ming Chiu L; Wong YS; Eng-Choon Ooi V
    Biomed Pharmacother; 2007 Oct; 61(9):578-87. PubMed ID: 17904792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy.
    Awasthi N; Schwarz MA; Schwarz RE
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):571-82. PubMed ID: 21110024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic effects of combination treatment with bortezomib and doxorubicin in human neuroblastoma cell lines.
    Du BY; Song W; Bai L; Shen Y; Miao SY; Wang LF
    Chemotherapy; 2012; 58(1):44-51. PubMed ID: 22327308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
    Lee CS; Kim YJ; Lee MS; Han ES; Lee SJ
    Life Sci; 2008 Sep; 83(13-14):481-9. PubMed ID: 18721818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytotoxicity and induction of apoptosis by formamidinodoxorubicins in comparison to doxorubicin in human ovarian adenocarcinoma cells.
    Marczak A; Denel-Bobrowska M; Rogalska A; Łukawska M; Oszczapowicz I
    Environ Toxicol Pharmacol; 2015 Jan; 39(1):369-83. PubMed ID: 25561091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer Cells.
    Wang L; Zhang X; Chan JY; Shan L; Cui G; Cui Q; Wang Y; Li J; Chen H; Zhang Q; Yu P; Han Y; Wang Y; Lee SM
    J Cell Biochem; 2016 Jan; 117(1):94-105. PubMed ID: 26058377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of doxorubicin on the expression of cyclin A in K-562 leukemia cell line.
    Grzanka A; Zuryń A; Styczyński J; Grzanka AA; Wisniewska H
    Neoplasma; 2005; 52(6):489-93. PubMed ID: 16284694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An Antifungal Mechanism of Protolichesterinic Acid from the Lichen
    Kumar SN; Mohandas C
    Front Pharmacol; 2017; 8():301. PubMed ID: 28611662
    [No Abstract]   [Full Text] [Related]  

  • 58. Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA.
    Heinicke U; Fulda S
    Cancer Lett; 2014 Aug; 351(1):50-8. PubMed ID: 24814395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Synergistic effect of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) and doxorubicin on human colon cancer SW480 cells].
    Xu LH; Deng CS; Zhu YQ; Liu SQ
    Ai Zheng; 2003 Aug; 22(8):816-20. PubMed ID: 12917026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of doxorubicin on TRAIL resistance and TRAIL receptor expression in lymphoma cell line SNK-6 cells].
    Zhang YC; Yang QP; Tang Y; Wang WY; Yu JB; Liu WP
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):651-4. PubMed ID: 24332050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.